Skip to main content

NU SKIN ENTERPRISES INC

For the period ended Mar 31, 2024. Filed May 9, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 9, 2024

NUS$4.03-5.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

Cash Flows (Unaudited)

Three Months Ended March 31,
20242023
Cash flows from operating activities:
Net (loss) income$(533)$11,376
Adjustments to reconcile net (loss) income to cash flows from operating activities:
Depreciation and amortization18,43716,983
Non-cash lease expense7,9878,566
Stock-based compensation4,2424,002
Inventory write-down2,0033,267
Foreign currency losses / (gains)1,639(2,102)
Loss / (gain) on disposal of assets218(17)
Deferred taxes1,348(72)
Changes in operating assets and liabilities:
Accounts receivable, net7,447(15,336)
Inventories, net6,999(23,001)
Prepaid expenses and other(13,352)(12,895)
Other assets(4,295)(864)
Accounts payable(10,575)(4,495)
Accrued expenses(4,227)(4,129)
Other liabilities(14,020)(3,360)
Net cash provided by / (used in) operating activities3,318(22,077)
Cash flows from investing activities:
Purchases of property and equipment(12,281)(11,487)
Proceeds on investment sales3,0194,986
Purchases of investments—(8,195)
Net cash used in investing activities(9,262)(14,696)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards(1,891)4,184
Payment of cash dividends(2,979)(19,392)
Finance lease principal payments(785)(912)
Contingent consideration payments(6,300)—
Payments of debt(20,000)(2,500)
Proceeds from debt—20,000
Net cash (used in) / provided by financing activities(31,955)1,380
Effect of exchange rate changes on cash(5,626)609
Net decrease in cash and cash equivalents(43,525)(34,784)
Cash and cash equivalents, beginning of period256,057264,725
Cash and cash equivalents, end of period$212,532$229,941
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.